Mingyao Liu
Tianjin University of Sport(CN)Capital Medical University(CN)Harbin Institute of Technology(CN)New York University Shanghai(CN)Sichuan Agricultural University(CN)Shanghai Medical Information Center(CN)Shandong Provincial Hospital(CN)Second Affiliated Hospital of Xi'an Jiaotong University(CN)Dalian National Laboratory for Clean Energy(CN)Beijing Children’s Hospital(CN)First Affiliated Hospital of Zhengzhou University(CN)East China Normal University(CN)Hainan Medical University(CN)Texas A&M University(US)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Immune Cell Function and Interaction, Receptor Mechanisms and Signaling, CAR-T cell therapy research, Ubiquitin and proteasome pathways
Most-Cited Works
- → Heritable gene targeting in the mouse and rat using a CRISPR-Cas system(2013)648 cited
- → Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma(2019)384 cited
- → Directional Sensing Requires Gβγ-Mediated PAK1 and PIXα-Dependent Activation of Cdc42(2003)374 cited
- → LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption(2016)359 cited
- → Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways(2008)353 cited
- → Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation(2002)350 cited